English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

142 elapsing polychondritis (RPC) is a rare immune-mediated condition, which targets particularly the cartilaginous tissue. RPC frequently attacks the ears, nose, eyes, joints and respiratory tract, but heart, kidneys may also be affected. The diversity of the affected anatomic regions and organs leads to a wide spectrum of clinical manifestations, which range from an occasional auricular inflammation to aortic and/or mitral valvular regurgitation or life -threatening tracheobronchomalacia.1 RPC may coexist with other diseases, such as systemic vasculitides, Graves’ disease or myelodysplastic syndrome. As of today, there are no established clinical or laboratory findings to predict the disease’s outcome. Relapsing Polychondritis Misdiagnosed and Treated as a “Soft Tissue Infection” and a Brief Review of Diagnostic Clinical Clues

Relapsing Polychondritis Misdiagnosed and Treated as a ''Soft Tissue Infection'' and a Brief Review of Diagnostic Clinical Clues